Kevin Marsh | Academic Influence

Kevin Marsh 's AcademicInfluence.com Rankings

Kevin Marsh

Engineering

#2478

World Rank

#3399

Historical Rank

Electrical Engineering

#449

World Rank

#500

Historical Rank

engineering Degrees

Kevin Marsh

Computer Science

#3436

World Rank

#3605

Historical Rank

Computational Linguistics

#175

World Rank

#179

Historical Rank

Machine Learning

#406

World Rank

#411

Historical Rank

Artificial Intelligence

#600

World Rank

#611

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Kevin Marsh 's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley
Bachelors Computer Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2025

Why Is Kevin Marsh Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kevin Marsh is a British Malariologist, academic and a researcher. He is a Professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.

(See a Problem?)

Kevin Marsh 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The pathogenic basis of malaria (2002) (1784)
Indicators of life-threatening malaria in African children. (1995) (1133)
Bacteremia among children admitted to a rural hospital in Kenya. (2005) (863)
Immunity to malaria: more questions than answers (2008) (845)
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. (1999) (756)
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa (1997) (736)
Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum (1989) (696)
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (2012) (689)
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria (1998) (684)
Rapid switching to multiple antigenic and adhesive phenotypes in malaria (1992) (668)
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. (1987) (658)
Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody (2011) (619)
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria (2004) (579)
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria (1995) (566)
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (2011) (531)
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria (1999) (520)
Insecticide‐treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast (1996) (509)
Immune effector mechanisms in malaria (2006) (505)
Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. (2009) (498)
Immunity to non-cerebral severe malaria is acquired after one or two infections (1999) (494)
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis (2007) (494)
Malaria: Biology and Disease (2016) (485)
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya (2008) (470)
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. (1989) (466)
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing (2012) (426)
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. (2008) (421)
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial (1999) (410)
Receptor-specific adhesion and clinical disease in Plasmodium falciparum. (1997) (400)
Plasmodium falciparum rosetting is associated with malaria severity in Kenya (1995) (395)
Genome-wide and fine-resolution association analysis of malaria in West Africa (2009) (394)
Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome (2010) (392)
Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria (2008) (384)
A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite (1988) (379)
Clinical features and pathogenesis of severe malaria. (2004) (361)
Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. (1986) (356)
Why do some African children develop severe malaria? (1991) (352)
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data (2015) (342)
Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting (2007) (334)
Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. (2005) (332)
Childhood deaths in Africa: uses and limitations of verbal autopsies (1992) (328)
Profile: The Kilifi Health and Demographic Surveillance System (KHDSS) (2012) (310)
Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. (2001) (304)
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. (2016) (304)
The past, present and future of childhood malaria mortality in Africa. (2001) (301)
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria (2004) (298)
Malaria-a neglected disease? (1992) (293)
The binding site on ICAM-1 for plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site (1992) (288)
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. (2015) (287)
The decline in paediatric malaria admissions on the coast of Kenya (2007) (285)
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study (2011) (284)
T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria (1984) (262)
Negative epistasis between the malaria-protective effects of α+-thalassemia and the sickle cell trait (2005) (259)
Averting a malaria disaster (1999) (256)
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. (2013) (255)
Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania (2011) (254)
Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya (2010) (251)
Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria (2015) (250)
Heritability of Malaria in Africa (2005) (247)
Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. (1994) (247)
Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion (2013) (244)
Bacteraemia complicating severe malaria in children. (1999) (238)
The consequences of reducing transmission of Plasmodium falciparum in Africa. (2002) (234)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial (2015) (233)
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. (2005) (230)
Changing home treatment of childhood fevers by training shop keepers in rural Kenya (1999) (230)
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control study (2009) (228)
A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. (1997) (225)
Malaria disaster in Africa (1998) (216)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. (2004) (213)
HYPOGLYCAEMIA IN AFRICAN CHILDREN WITH SEVERE MALARIA (1987) (212)
An Immune Basis for Malaria Protection by the Sickle Cell Trait (2005) (212)
Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. (2004) (210)
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria (2014) (208)
Intracranial pressure in African children with cerebral malaria (1991) (207)
Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. (2012) (204)
Chronic Exposure to (2013) (203)
Antibody Recognition of Plasmodium falciparum Erythrocyte Surface Antigens in Kenya: Evidence for Rare and Prevalent Variants (1999) (202)
Severe anaemia in children living in a malaria endemic area of Kenya (1997) (202)
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya (2000) (202)
The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast. (1999) (201)
Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. (1996) (200)
Cognitive sequelae of severe malaria with impaired consciousness. (1999) (199)
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. (2008) (197)
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life (2007) (197)
Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae (2001) (195)
Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. (1995) (195)
Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. (2000) (190)
Reappraisal of known malaria resistance loci in a large multi-centre study (2014) (190)
Plasmodium falciparum Variant Surface Antigen Expression Patterns during Malaria (2005) (190)
Intracranial hypertension in Africans with cerebral malaria (1997) (190)
The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. (1992) (187)
Trust and informed consent: insights from community members on the Kenyan coast. (2005) (186)
Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. (2008) (185)
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria (2004) (180)
'Even if they ask you to stand by a tree all day, you will have to do it (laughter)...!': community voices on the notion and practice of informed consent for biomedical research in developing countries. (2005) (177)
Malaria and the Red Cell (1982) (176)
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial (2011) (172)
A novel locus of resistance to severe malaria in a region of ancient balancing selection (2015) (171)
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. (2002) (171)
Chloroquine resistance before and after its withdrawal in Kenya (2009) (171)
Fresh Isolates from Children with Severe Plasmodium falciparum Malaria Bind to Multiple Receptors (2001) (170)
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. (2009) (170)
Iron deficiency and malaria among children living on the coast of Kenya. (2004) (168)
Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin (1987) (167)
Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study (2005) (166)
Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. (2005) (164)
The Effect of α +-Thalassaemia on the Incidence of Malaria and Other Diseases in Children Living on the Coast of Kenya (2006) (163)
Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. (1998) (162)
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1 (2009) (162)
New antigens for a multicomponent blood-stage malaria vaccine (2014) (161)
Clinical overlap between malaria and severe pneumonia in Africa children in hospital. (1996) (158)
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya (2006) (157)
Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. (2007) (156)
Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. (2007) (156)
Plasmodium falciparum var gene expression is modified by host immunity (2009) (155)
Brain swelling and ischaemia in Kenyans with cerebral malaria. (1994) (154)
Seizures and status epilepticus in childhood cerebral malaria. (1996) (154)
Sickle cell disease in Africa: burden and research priorities (2007) (153)
A global network for investigating the genomic epidemiology of malaria (2008) (153)
Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. (1992) (151)
Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. (2010) (150)
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity (2017) (150)
Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study (2000) (149)
Improving malaria home treatment by training drug retailers in rural Kenya (2004) (148)
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. (2006) (146)
Malaria and nutritional status in children living on the coast of Kenya. (2004) (145)
Malaria transmission and morbidity. (1999) (144)
The Selection Landscape of Malaria Parasites (2010) (142)
Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome. (1996) (142)
Will reducing Plasmodium falciparum transmission alter malaria mortality among african children (1995) (141)
Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. (2003) (138)
Pathophysiology of severe malaria in children. (2004) (136)
Specific Receptor Usage in Plasmodium falciparum Cytoadherence Is Associated with Disease Outcome (2011) (135)
Host-parasite interaction and morbidity in malaria endemic areas. (1997) (134)
Resistance to malaria through structural variation of red blood cell invasion receptors (2017) (131)
Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria (2002) (131)
Mapping of the Region of Complement Receptor (CR) 1 Required for Plasmodium falciparum Rosetting and Demonstration of the Importance of CR1 in Rosetting in Field Isolates1 (2000) (129)
Epileptic seizures and malaria in Kenyan children. (1996) (129)
A LAIR-1 insertion generates broadly reactive antibodies against malaria variant antigens (2015) (126)
Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria (2001) (126)
Cerebral malaria versus bacterial meningitis in children with impaired consciousness. (1999) (126)
Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies (2006) (125)
A non-sense mutation in Cd36 gene is associated with protection from severe malaria (2001) (124)
A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots (2014) (123)
Genomewide analysis of the host response to malaria in Kenyan children. (2005) (123)
Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description. (2003) (123)
Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. (2005) (123)
Clinical algorithms for malaria diagnosis lack utility among people of different age groups (2005) (122)
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults (2015) (122)
Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. (1989) (121)
Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study (2003) (120)
Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4+ CD25high T Cells with Susceptibility in Kenyans (2008) (120)
Malaria eradication and elimination: views on how to translate a vision into reality (2015) (118)
B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. (2005) (117)
Acidosis in severe childhood malaria. (1997) (117)
Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast (2011) (116)
Defining Childhood Severe Falciparum Malaria for Intervention Studies (2007) (115)
The pathogenesis of severe malaria in African children. (1996) (115)
Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. (2003) (115)
Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa (2001) (114)
New insights into the epidemiology of malaria relevant for disease control. (1998) (113)
The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. (1994) (111)
Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia (1991) (110)
Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure (2009) (109)
High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. (2010) (109)
A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production (2002) (108)
A review of the spectrum of clinical ocular fundus findings in P. falciparum malaria in African children with a proposed classification and grading system. (1999) (108)
BED-NETS (MOSQUITO-NETS) AND MORBIDITY FROM MALARIA (1986) (107)
Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum (2008) (107)
A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa (2011) (107)
Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. (2008) (104)
Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. (1988) (104)
Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. (1994) (104)
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection (2014) (103)
The need for maps of transmission intensity to guide malaria control in Africa (1996) (103)
Malaria in Africa: progress and prospects in the decade since the Abuja Declaration (2010) (102)
A Library of Functional Recombinant Cell-surface and Secreted P. falciparum Merozoite Proteins* (2013) (102)
Hyponatraemia and dehydration in severe malaria. (1996) (101)
Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria. (2002) (100)
Imputation-Based Meta-Analysis of Severe Malaria in Three African Populations (2013) (100)
The role of reduced red cell deformability in the pathogenesis of severe falciparum malaria and its restoration by blood transfusion. (2002) (100)
Short report: Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. (2002) (99)
Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum infected erythrocytes from Gambian patients (1986) (99)
Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. (2001) (98)
Infection with Pneumocystis carinii is prevalent in healthy Gambian children. (1990) (96)
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria (2011) (95)
Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks (2008) (95)
The Induction and Persistence of T Cell IFN-γ Responses after Vaccination or Natural Exposure Is Suppressed by Plasmodium falciparum1 (2007) (93)
Coma scales for children with severe falciparum malaria. (1997) (91)
Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. (1991) (91)
Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome (2002) (90)
Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. (2005) (90)
Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. (1993) (90)
Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? (2000) (89)
Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children. (2002) (88)
Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children (2012) (88)
IgM in human immunity to Plasmodium falciparum malaria (2019) (87)
Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. (2011) (87)
Plasmodium falciparum STEVOR Proteins Are Highly Expressed in Patient Isolates and Located in the Surface Membranes of Infected Red Blood Cells and the Apical Tips of Merozoites (2008) (86)
Comparative Transcriptional and Genomic Analysis of Plasmodium falciparum Field Isolates (2009) (85)
Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2 (2002) (84)
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy. (2009) (84)
The changing limits and incidence of malaria in Africa: 1939-2009. (2012) (84)
Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. (1996) (83)
Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya (2012) (83)
Prospective Identification of Malaria Parasite Genes under Balancing Selection (2009) (83)
Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria (1997) (82)
PfEMP1, polymorphism and pathogenesis. (1997) (82)
Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study (2016) (81)
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study (2019) (81)
The Frequency of BDCA3-Positive Dendritic Cells Is Increased in the Peripheral Circulation of Kenyan Children with Severe Malaria (2006) (79)
Clinical Features of Malaria (1999) (79)
An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. (1996) (79)
How useful are verbal autopsies to estimate childhood causes of death (1992) (79)
Haemoglobin C and S Role in Acquired Immunity against Plasmodium falciparum Malaria (2007) (79)
Prognostic Indicators of Life-Threatening Malaria Are Associated with Distinct Parasite Variant Antigen Profiles (2012) (78)
Environmental and entomological risk factors for the development of clinical malaria among children on the Kenyan coast. (1998) (78)
Hepatitis B virus infection as a neglected tropical disease (2017) (77)
Autoagglutination of malaria-infected red blood cells and malaria severity (2000) (77)
Hypoglycaemia on and after admission in Kenyan children with severe malaria. (1998) (76)
Transport of an Mr approximately 300,000 Plasmodium falciparum protein (Pf EMP 2) from the intraerythrocytic asexual parasite to the cytoplasmic face of the host cell membrane (1987) (76)
Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya (2007) (76)
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections. (2004) (74)
An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya. (1998) (74)
Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. (1992) (73)
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. (1992) (73)
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria☆ (2013) (73)
Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children (2011) (73)
Transfusion for respiratory distress in life-threatening childhood malaria. (1996) (73)
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study (2018) (73)
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study (2018) (73)
Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. (2009) (72)
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes (2009) (72)
Allele Frequency–Based and Polymorphism-Versus-Divergence Indices of Balancing Selection in a New Filtered Set of Polymorphic Genes in Plasmodium falciparum (2010) (72)
Pre‐transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion (2005) (71)
Clinical Research in Resource-Limited Settings: Enhancing Research Capacity and Working Together to Make Trials Less Complicated (2010) (69)
Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum (2001) (69)
An approach to classifying sequence tags sampled from Plasmodium falciparum var genes (2007) (67)
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial (2002) (66)
Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. (1997) (66)
Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3 (2007) (66)
Acridine orange fluorescence techniques as alternatives to traditional Giemsa staining for the diagnosis of malaria in developing countries. (1996) (66)
Chronic salicylate poisoning and severe malaria (1996) (65)
Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya (2013) (65)
Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. (1998) (65)
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. (2015) (65)
The role of the district hospital in child survival at the Kenyan Coast. (1994) (65)
Electroencephalographic and clinical features of cerebral malaria (2001) (65)
Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children (2008) (64)
Genomic representation of var gene sequences in Plasmodium falciparum field isolates from different geographic regions. (1997) (64)
Inflammatory mediators in children with protein-energy malnutrition. (1997) (64)
The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children (1990) (64)
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia (2016) (64)
CISH and susceptibility to infectious diseases. (2010) (64)
Glucose homeostasis in children with falciparum malaria: precursor supply limits gluconeogenesis and glucose production. (1997) (64)
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. (1997) (64)
The impact of primary health care on malaria morbidity – defining access by disease burden (2009) (63)
Perceptions of symptoms of severe childhood malaria among Mijikenda and Luo residents of Coastal Kenya (1995) (62)
Photographic and angiographic characterization of the retina of Kenyan children with severe malaria. (1997) (62)
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya (2015) (61)
Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. (2006) (61)
The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children (2013) (61)
Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. (2013) (60)
Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. (2012) (60)
Lactic acidosis and oxygen debt in African children with severe anaemia. (1997) (60)
Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. (2007) (60)
Erythrocyte-Binding Antigens of Plasmodium falciparum Are Targets of Human Inhibitory Antibodies and Function To Evade Naturally Acquired Immunity (2013) (60)
Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. (2006) (59)
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity (2009) (59)
The Plasma Concentration of the B Cell Activating Factor Is Increased in Children With Acute Malaria (2011) (58)
Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in Kenya (2010) (58)
Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya. (1997) (58)
Lack of Association of Interferon Regulatory Factor 1 with Severe Malaria in Affected Child-Parental Trio Studies across Three African Populations (2009) (58)
A model for estimating total parasite load in falciparum malaria patients. (2002) (58)
The effects of malaria control on nutritional status in infancy. (1997) (58)
Adaptation of Plasmodium falciparum to its transmission environment (2017) (57)
Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. (1991) (57)
An observational study of children with sickle cell disease in Kilifi, Kenya (2009) (57)
Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania (2019) (57)
Chemosensitization of Plasmodium falciparum by Probenecid In Vitro (2003) (56)
Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. (2002) (56)
WHO, the Global Fund, and medical malpractice in malaria treatment (2004) (56)
Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population. (1988) (56)
Infant parasite rates and immunoglobulin M seroprevalence as a measure of exposure to Plasmodium falciparum during a randomized controlled trial of insecticide-treated bed nets on the Kenyan coast. (1996) (55)
Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. (2007) (55)
Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania (2011) (55)
Transmission-dependent tolerance to multiclonal Plasmodium falciparum infection. (2009) (54)
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area. (2006) (53)
Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium. (2005) (52)
Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. (2009) (51)
The effects of untreated bednets on malaria infection and morbidity on the Kenyan coast. (2003) (51)
An increase in the burden of neonatal admissions to a rural district hospital in Kenya over 19 years (2010) (51)
Inflammatory mediators in children with protein-energy (1997) (50)
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? (2005) (50)
Promoting the social value of research in Kenya: Examining the practical aspects of collaborative partnerships using an ethical framework (2008) (49)
Development of a malaria vaccine (1997) (49)
Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. (2005) (49)
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. (2009) (49)
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. (2006) (49)
Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast (2016) (48)
Variation in the ICAM1 gene is not associated with severe malaria phenotypes (2008) (48)
The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya. (2007) (48)
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines (2014) (48)
Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria. (2003) (48)
Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis (2019) (48)
Intermittent Preventive Sulfadoxine-Pyrimethamine Treatment of Primigravidae Reduces Levels of Plasma Immunoglobulin G, Which Protects against Pregnancy-Associated Plasmodium falciparum Malaria (2004) (46)
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014) (2015) (46)
Congenital and neonatal malaria in a rural Kenyan district hospital: An eight-year analysis (2010) (46)
Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay (2011) (46)
Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness (2009) (46)
Estimation of the sequestered parasite load in severe malaria patients using both host and parasite markers (2005) (45)
Helminth Infection and Eosinophilia and the Risk of Plasmodium falciparum Malaria in 1- to 6-Year-Old Children in a Malaria Endemic Area (2008) (45)
Parasite-infected-cell-agglutination and indirect immunofluorescence assays for detection of human serum antibodies bound to antigens on Plasmodium falciparum-infected erythrocytes. (1986) (45)
Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast (2011) (44)
Regulation of immune response by Plasmodium‐infected red blood cells (2005) (44)
Invasion Pathways and Malaria Severity in Kenyan Plasmodium falciparum Clinical Isolates (2007) (44)
Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children (2016) (44)
Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection. (2003) (43)
Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field (2012) (43)
Homozygosity and risk of childhood death due to invasive bacterial disease (2009) (42)
Whole-Genome Scans Provide Evidence of Adaptive Evolution in Malawian Plasmodium falciparum Isolates (2014) (42)
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya (2014) (41)
Abnormal respiratory patterns in childhood cerebral malaria. (1998) (41)
Interobserver variation in respiratory signs of severe malaria. (1995) (41)
Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya. (2005) (41)
Plasmodium falciparum intercellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells. (2007) (41)
Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from west African patients. (1991) (40)
Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria (2013) (39)
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting (2013) (39)
Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya (2010) (39)
The accuracy of the clinical histories given by mothers of seriously ill African children. (1987) (39)
High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections. (2012) (39)
Hypothetical performance of syndrome-based management of acute paediatric admissions of children aged more than 60 days in a Kenyan district hospital. (2003) (39)
Maternal recall of symptoms associated with childhood deaths in rural east Africa. (1993) (39)
Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum Parasites (2011) (38)
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data (2013) (38)
Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children (2008) (38)
Genome Wide Adaptations of Plasmodium falciparum in Response to Lumefantrine Selective Drug Pressure (2012) (37)
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine (1985) (37)
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies (2015) (37)
Induction of T Helper Type 1 and 2 Responses to 19-Kilodalton Merozoite Surface Protein 1 in Vaccinated Healthy Volunteers and Adults Naturally Exposed to Malaria (2002) (36)
Paediatric survival and re‐admission risks following hospitalization on the Kenyan Coast (2000) (35)
Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family. (2006) (35)
Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates (MSP3 and GLURP) (2014) (34)
Naturally acquired immunity to Plasmodium falciparum (1991) (34)
Progressive Increase in Antimicrobial Resistance among Invasive Isolates of Haemophilus influenzae Obtained from Children Admitted to a Hospital in Kilifi, Kenya, from 1994 to 2002 (2005) (34)
Factors influencing admission to hospital during terminal childhood illnesses in Kenya. (1994) (34)
Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naïve and Malaria-Exposed Individuals (2006) (33)
Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance (2017) (33)
Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy. (1993) (33)
Antibodies to voltage-gated calcium channels in children with falciparum malaria. (2005) (32)
Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects. (1992) (31)
Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations (2014) (31)
Vector-related case-control study of severe malaria in Kilifi District, Kenya. (1999) (31)
Repeated clinical malaria episodes are associated with modification of the immune system in children (2019) (31)
Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria (2010) (31)
Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya (2012) (30)
The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes. (2004) (30)
Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. (1994) (30)
Diagnosis of pneumococcal pneumonia in epidemiological studies: evaluation in Kenyan adults of a serotype-specific urine latex agglutination assay. (1999) (30)
Phenotypic and Functional Profiling of CD4 T Cell Compartment in Distinct Populations of Healthy Adults with Different Antigenic Exposure (2013) (30)
Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus (2007) (30)
A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants (2004) (30)
Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum (1990) (30)
The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19 (2020) (30)
Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models (2015) (29)
Studies of the receptors on melanoma cells for Plasmodium falciparum infected erythrocytes. (1989) (29)
KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization (2018) (29)
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya (2019) (29)
Research priorities for malaria elimination (2010) (29)
Diagnosis of Pneumococcal Pneumonia by psaA PCR Analysis of Lung Aspirates from Adult Patients in Kenya (2003) (28)
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure (2017) (28)
Identification of frequently recognized dimorphic T-cell epitopes in plasmodium falciparum merozoite surface protein-1 in West and East Africans: lack of correlation of immune recognition and allelic prevalence. (2001) (28)
Alternating vector immunizations encoding pre‐erythrocytic malaria antigens enhance memory responses in a malaria endemic area (2006) (28)
Binding of Plasmodium falciparum-infected erythrocytes to soluble platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): frequent recognition by clinical isolates. (2001) (28)
A Genome Wide Association Study of Plasmodium falciparum Susceptibility to 22 Antimalarial Drugs in Kenya (2014) (27)
Plasmodium falciparum var Gene Expression Homogeneity as a Marker of the Host-Parasite Relationship under Different Levels of Naturally Acquired Immunity to Malaria (2013) (27)
Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children (2017) (27)
Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1 (2008) (27)
Screening for severe anaemia in pregnancy in Kenya, using pallor examination and self-reported morbidity. (2001) (26)
Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (26)
Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children (2014) (26)
Thrombospondin binding by parasitized erythrocyte isolates in falciparum malaria. (1987) (25)
Analysis of Antibodies to Newly Described Plasmodium falciparum Merozoite Antigens Supports MSPDBL2 as a Predicted Target of Naturally Acquired Immunity (2013) (25)
CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas. (2002) (25)
Ultrastructure of the erythrocytic stages of Plasmodium malariae. (1987) (24)
Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children (2009) (24)
Cellular reactivity to the p. Falciparum protein trap in adult kenyans: novel epitopes, complex cytokine patterns, and the impact of natural antigenic variation. (2006) (24)
Cytokine mRNA Expression and Iron Status in Children Living in a Malaria Endemic Area (2005) (24)
Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine. (1995) (24)
PEST CONTROL Cockroaches as carriers of bacteria (1993) (24)
Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya (2015) (24)
Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2015) (23)
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity (2015) (23)
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. (2021) (23)
Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. (2002) (23)
Case-control studies of severe malaria. (1992) (22)
Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children (2011) (22)
Antibody mediated strain‐specific agglutination of Plasmodium falciparum—parasitized erythrocytes visualized by ethidium bromide staining (1985) (22)
Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection (2016) (21)
Bayesian age-stage modelling of Plasmodium falciparum sequestered parasite loads in severe malaria patients (2004) (21)
The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum – an epidemiological “natural experiment” (2016) (21)
Antigenic diversity and size diversity of Plasmodium falciparum antigens in isolates from Gambian patients. I. S‐antigens (1986) (21)
A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children. (2005) (21)
Blood transfusions for severe anaemia in African children (1992) (21)
Plasmodium falciparum antigenic variation: relationships between widespread endothelial activation, parasite PfEMP1 expression and severe malaria (2014) (21)
Surface Antigen Expression on Plasmodium falciparum-infected Erythrocytes Is Modified in cx-and f Thalassemia By (20)
The relationship between glucose production and plasma glucose concentration in children with falciparum malaria. (1996) (20)
Naturally acquired immunity to Plasmodium falciparum. (1991) (20)
CD4 T Cells from Malaria-Nonexposed Individuals Respond to the CD36-Binding Domain of Plasmodium falciparum Erythrocyte Membrane Protein-1 via an MHC Class II-TCR-Independent Pathway1 (2006) (20)
In Vitro Activities of 2,4-Diaminoquinazoline and 2,4-Diaminopteridine Derivatives against Plasmodium falciparum (2004) (20)
Elevated plasma urokinase receptor predicts low birth weight in maternal malaria (2007) (20)
Plasmodium falciparum: a method for the amplification of S antigens and its application to laboratory and field samples. (1993) (19)
CD4+ T Cell Responses to the Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Mild Malaria (2014) (19)
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. (2008) (19)
Therapeutic potential of folate uptake inhibition in Plasmodium falciparum. (2004) (19)
Inhibition of Plasmodium falciparum growth by IgG antibody produced by human lymphocytes transformed with Epstein-Barr virus. (1986) (19)
A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies (2016) (18)
Molecular approaches to epidemiology and clinical aspects of malaria. (2000) (18)
The epidemiology of clinical malaria among African children. (1998) (18)
The effect of Plasmodium falciparum infection on expression of monocyte surface molecules. (2006) (18)
PROGNOSTIC VALUE OF CSF LACTATE IN CEREBRAL MALARIA (1987) (17)
Clinical algorithm for malaria in Africa (1996) (17)
Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life (2017) (17)
Tuberculosis among the residents of hostels and lodging-houses in London. (1957) (16)
The influence of alanine infusion on glucose production in 'malnourished' African children with falciparum malaria. (1997) (16)
Malaria protection due to sickle haemoglobin depends on parasite genotype (2021) (15)
Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa (2003) (15)
Association of the GNAS locus with severe malaria (2008) (15)
Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity (2016) (14)
CD4 T Cells from Malaria-Nonexposed Individuals Respond to the CD36-Binding Domain of Plasmodium falciparum Erythrocyte Membrane Protein-1 via an MHC Class II-TCR-Independent Pathway (2006) (14)
Mortality Among Kenyan Children Admitted to a Rural District Hospital on Weekends as Compared With Weekdays (2004) (14)
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria. (1995) (13)
A single dose of intramuscular sulfadoxine-pyrimethamine as an adjunct to quinine in the treatment of severe malaria: pharmacokinetics and efficacy. (1993) (13)
Chloroquine is not a risk factor for seizures in childhood cerebral malaria (2000) (13)
Signs of Dehydration in Severe Childhood Malaria (1997) (13)
Funding and COVID-19 research priorities - are the research needs for Africa being met? (2020) (13)
T-Cell Responses to the DBLα-Tag, a Short Semi-Conserved Region of the Plasmodium falciparum Membrane Erythrocyte Protein 1 (2012) (13)
Impact of UK malaria prophylaxis policy on imported malaria (1996) (12)
Doxycycline for the treatment of nodding syndrome (DONS); the study protocol of a phase II randomised controlled trial (2019) (12)
Plasmodium falciparum Infection Patterns Since Birth and Risk of Severe Malaria: A Nested Case-Control Study in Children on the Coast of Kenya (2013) (12)
Frequencies of peripheral blood myeloid cells in healthy Kenyan children with alpha+ thalassemia and the sickle cell trait. (2006) (12)
Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolates (2009) (11)
The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children (2005) (10)
Gene copy number variation in natural populations of Plasmodium falciparum in Eastern Africa (2018) (10)
Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study (2020) (10)
Absence of crisis form factor in subjects immune to Plasmodium falciparum in The Gambia, West Africa. (1987) (10)
Prevalence, causes, and behavioral and emotional comorbidities of acute symptomatic seizures in Africa: A critical review (2017) (10)
Impact of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya (2018) (10)
30 years of science and technology: the example of malaria (1997) (10)
Use of gene expression studies to investigate the human immunological response to malaria infection (2019) (10)
Association of the TNF-238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa (1996) (10)
Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population (2016) (9)
Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort. (2019) (9)
A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 E on blood stage immunity in young Kenyan children (2019) (9)
Antigens on the Plasmodium falciparum infected erythrocyte surface are parasite derived: a reply. (1990) (9)
Phase Iib, Randomized, Double-Blind Trial to Assess the Efficacy, Safety and Immunogenicity of the Candidate Malaria Vaccine Rts,S/As01 in Kenyan and Tanzanian Children (2008) (9)
Retinal haemorrhages in falciparum malaria. (1991) (9)
Correction: Imputation-Based Meta-Analysis of Severe Malaria in Three African Populations (2013) (8)
Africa in transition: the case of malaria. (2016) (8)
High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria (2017) (8)
Individual-level variations in malaria susceptibility and acquisition of clinical protection. (2021) (8)
Immunity to febrile malaria in children: an analysis (2009) (8)
Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya. (1998) (7)
Malaria in East Africa (1997) (7)
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long‐standing nodding syndrome: A case‐control study (2020) (7)
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity. (2021) (7)
Asymptomatic malaria parasitaemia and seizure control in children with nodding syndrome; a cross-sectional study (2018) (7)
Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis (2019) (7)
New insights into malaria susceptibility from the genomes of 17,000 individuals from Africa, Asia, and Oceania (2019) (7)
Video assessment of simple respiratory signs (1996) (6)
Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria (2007) (6)
Temporal Association of Acute Hepatitis A and Plasmodium falciparum Malaria in Children (2011) (6)
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria (2022) (6)
Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection (2019) (6)
Negative epistasis between the malaria-protective effects of alpha (+) thalassaemia and the sickle cell trait [MIM-TW-395505] (2005) (6)
Epilepsy in Onchocerca volvulus Sero-Positive Patients From Northern Uganda—Clinical, EEG and Brain Imaging Features (2021) (6)
Household poverty, schooling, stigma and quality of life in adolescents with epilepsy in rural Uganda (2020) (6)
Tumor Necrosis Factor and Lymphotoxin-α Polymorphisms and Severe Malaria in African Populations (2009) (6)
Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders (2021) (6)
Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes (2021) (6)
Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria (2016) (6)
Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) (2019) (6)
Immunity to malaria: more questions than (2008) (5)
Prolonged chemotherapy in chronic pulmonary tuberculosis with combinations of isoniazid, para-aminosalicylic acid, and streptomycin. (1956) (5)
Clinical algorithm for malaria in Africa. (1996) (5)
Exploring Plasmodium falciparum Var Gene Expression to Assess Host Selection Pressure on Parasites During Infancy (2019) (5)
Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort (2019) (5)
A functional variant in TIRAP , also known as MAL , and protection against invasive pneumococcal disease , bacteraemia , malaria and tuberculosis (2009) (5)
Parasitized erythrocyte antigens and thrombospondin adhesion in the immunology and pathogenesis of falciparum malaria. (1986) (5)
MALARIA Patarroyo's vaccine (1993) (5)
Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis (2022) (5)
Risk Factors for Nodding Syndrome and Other Forms of Epilepsy in Northern Uganda: A Case-Control Study (2021) (4)
Hospital orientation for children. (1979) (4)
An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol (2018) (4)
The impact of 10-valent Pneumococcal Conjugate Vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children (2018) (4)
Genomic epidemiology of the current wave of artemisinin resistant malaria (2015) (4)
Management of severe malaria: implications for research. (2003) (4)
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response (2022) (4)
Outcome of cardiopulmonary resuscitation in hospitalized African children. (2001) (4)
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples (2023) (3)
Individual-level variations in malaria susceptibility and acquisition of clinical protection. (2021) (3)
CLONAL VARIATION OF THE RED-CELL SURFACE PHENOTYPES IN MALARIA (1993) (3)
DOES CHLOROQUINE CAUSE HYPOGLYCAEMIA IN THE ABSENCE OF CLINICAL MALARIA? (1987) (3)
AN INCOMPLETE VICTORY (1955) (3)
Hypothetical performance of syndrome based management of acute paediatric admissions aged over 60 days in a Kenyan district hospital (2003) (3)
Epidemiological aspects of severe and complicated malaria : research needs (1993) (3)
Mortality in sickle cell anaemia in Africa: rates and risk factors from a prospective cohort study in Tanzania (2011) (3)
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency (2020) (3)
Multiple Receptors Malaria Bind to Plasmodium falciparum Fresh Isolates from Children with Severe (2001) (3)
Quinine dose recommendations in childhood malaria—a reply (1995) (3)
Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria (2020) (2)
Antigenic diversity and size diversity of P. falciparum antigens in isolates from Gambian patients. II. the schizont surface glycoprotein of molecular weight approximately 200 000. (1986) (2)
The protective effect of sickle cell haemoglobin against severe malaria depends on parasite genotype (2021) (2)
HIV , Malnutrition and Invasive Bacterial Infection among Children with Severe Malaria (2012) (2)
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria (2023) (2)
Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya (2021) (2)
A non-sense mutation and protection from severe malaria (2001) (2)
Clinical malaria: new problems in patient management (1991) (2)
Childhood malaria – pathogenesis and treatment (1997) (2)
Safety, immunogenicity and efficacy studies of candidate malaria vaccines FP9 and MVA encoding ME-TRAP in Kenyan children [MIM-PB-224908] (2005) (2)
Artemesinins for severe malaria in Africa? (2002) (2)
Blood group O protects against severe Plasmodium faiciparum malaria (2007) (2)
A structural variant encoding hybrid glycophorins is associated with resistance to severe malaria (2016) (2)
Sickle cell anaemia in East Africa: Preliminary results from a cohort study. (2006) (2)
T5.8: Malaria in Africa: sources, risks, drivers and disease burden 2005-2030 (2006) (2)
The acquisition and maintenance of antibodies against Plasmodium falciparum merozoite antigens in childhood (2007) (2)
Plasmodium falciparum glycolipid synthesis: constant and variant molecules of isolates and of strains with differing knob and cytoadherence phenotype. (1988) (2)
invasive disease in sub-Saharan Africa have a distinct genotype Typhimurium causing Salmonella Epidemic multiple drug resistant Material Supplemental (2009) (2)
The accuracy of the clinical histories given by mothers of sick African children. (1987) (2)
B cell memory to three P. falciparum blood stage antigens in an endemic area (2005) (2)
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity (2022) (2)
Comparison of Structural Changes in Nodding Syndrome and Other Epilepsies Associated With Onchocerca volvulus (2022) (2)
Malaria policy advisory committee to the WHO: conclusions and recommendations of fifth biannual meeting (March 2014) (2014) (2)
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity. (2021) (1)
The MSPDBL2 Codon 591 Polymorphism Is Associated with Lumefantrine In Vitro Drug Responses in Plasmodium falciparum Isolates from Kilifi, Kenya (2014) (1)
Blood transfusions for severe anaemia in African children. (1992) (1)
HLA associated differential susceptibility to severe malaria in children from Kilifi, Kenya: A case-control study (1994) (1)
Erratum to ‘‘Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection” [Int. J. Parasitol. 42 (2012) 535–548] (2012) (1)
Geographic population structure of the immune evasion (var) genes of Plasmodium falciparum [résumé de poster] (2008) (1)
Improvement of Plasmodium Falciparum erythrocyte membrane protein-1 (PfEMP-1) vaccine antigens using directed molecular evolution (2005) (1)
Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (1)
Cyclophosphamide plus emetine in lung cancer. (1972) (1)
Relapse rates after chemotherapy in chronic fibrocaseous pulmonary tuberculosis. (1955) (1)
The role of PfRh invasion ligands as targets of antibodies that protect against P-falciparum malaria. (2008) (1)
Cerebral malaria (1991) (1)
Malaria and Nutritional Status in Children Living on the Coast of Kenya (2004) (1)
Plasmodium falciparum Icam-1-based cytoadherence-related signalling in endothelical cells (2008) (1)
Correction: Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya (2011) (1)
Green Heroes (1995) (1)
Common Antimalarial Drugs Do Not Affect Metabolism of Diazepam and Desmethyldiazepam by Human Liver Microsomes In‐vitro (1996) (1)
Individual-level variations in malaria susceptibility and acquisition of clinical protection (2022) (1)
Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial (2021) (1)
TumorNecrosis Factor Production byHumanMacrophages Stimulated InVitro byPlasmodium falciparum (1990) (1)
CEREBRAL MALARIA - REPLY (1991) (1)
SUBCLAVIAN VEIN THROMBOSIS DUE TO EXTERNAL COMPRESSION (1980) (1)
outcome at the outpatient clinic and during hospitalization Malaria in patients with sickle cell anemia: burden, risk factors, and (2013) (1)
Plasmodium falciparum cytoadherence to ICAM-1 is associated with cerebral malaria (2010) (1)
The British society for parasitology malaria meeting (1989) (1)
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis (2022) (1)
Private sector drug retailers and malaria control in Kenya (2003) (1)
Correction: Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya (2011) (1)
Cerebrospinal fluid concentrations of quinolinic acid. Total neopterin and nitrate plus nitrite in Kenyan children recovering from cerebral malaria. (1997) (1)
PfEMP1 is the major target of antibodies to the surface of P-falciparum-infected erythrocytes that are associated with protection from malaria. (2008) (1)
Sharing methods for global health research: an assessment of methodology (2013) (1)
Volume Status in Severe Malaria: No Evidence Provided for the Degree of Filling of the Intravascular Compartment (2005) (1)
Diagnosis of bacterial meningitis (2001) (1)
Antibody acquisition against apical membrane antigen 1 in a cohort of children and the relationship to malaria exposure and protective immunity [MIM-CM-40691] (2005) (0)
Studies of natural selection on malaria parasite merozoites in relation to invasion and immunity. (2008) (0)
The EBA and PfRh invasion ligand families of P-falciparum as targets of invasion-inhibitory and protective antibodies. (2008) (0)
Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations (2014) (0)
Plasmodium falciparum var gene expression patterns in children with different levels of immunity to malaria. (2008) (0)
Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2015) (0)
Is Suppressed by Responses after Vaccination or Natural Exposure γ The Induction and Persistence of T Cell IFN (2011) (0)
Class II-TCR-Independent Pathway Erythrocyte Membrane Protein-1 via an Plasmodium falciparum Domain of Individuals Respond to the CD 36-Binding CD 4 T Cells from Malaria-Nonexposed (2006) (0)
The role of malaria infection in morbidity and mortality in sickle cell disease in east africa: Preliminary evidence from a cohort study [MIM-JM-1200] (2005) (0)
Antibodies and Function To Evade Naturally falciparum Are Targets of Human Inhibitory Erythrocyte-Binding Antigens of Plasmodium (2013) (0)
Gene copy number variation in natural populations of Plasmodium falciparum in Eastern Africa (2018) (0)
Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial (2021) (0)
Pharmacology of absorption and distribution: optimal use of antimalarial drugs in the treatment of severe falciparum malaria in Kenya. (1994) (0)
Allele frequency based tests of neutrality on eba-175 and ebl-1 in Plasmodium falciparum populations from Kenya and Thailand [MIM-FV-66780] (2005) (0)
Plasmodium fialciparum antigenic variation: Differential expression of var gene subsets during clinical malaria [MIM-PB-40686] (2005) (0)
Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (0)
Biphasic Clinical Course Among Kenyan Children With Cerebral Malaria (2008) (0)
QUANTIFYING THE IMPORTANCE OF PFEMP1 AND OTHER ANTIGENS EXPRESSED ON THE SURFACE OF PLASMODIUM FALCIPARUM-INFECTED ERYTHROCYTES AS TARGETS OF PROTECTIVE ANTIBODIES AGAINST MALARIA (2010) (0)
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya (2015) (0)
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies (2015) (0)
Additional file 4: of Observational study: 27Â years of severe malaria surveillance in Kilifi, Kenya (2019) (0)
Limited global diversity of antibody epitopes expressed by placental binding Plasmodium falciparum variants. (2008) (0)
severe malaria . Interobserver variation in respiratory signs of (2006) (0)
The acquisition and maintenance of antibodies against P-falciparum merozoite antigens in childhood. (2008) (0)
An assessment of the impact of host polymorphisms on Plasmodium falciparum vargene expression patterns among Kenyan children (2014) (0)
Isolatesthe Importance of CR1 in Rosetting in Field Rosetting and Demonstration of falciparum Plasmodium Receptor (CR) 1 Required for Mapping of the Region of Complement (2000) (0)
Safety and immunogenicity of the candidate malaria vaccines FP9 ME-TRAP and MVA METRAP in semi-immune adult males [MIM-OK-87312] (2005) (0)
Charles Darwin University Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya Borrmann, (2013) (0)
Assessment of local networking strategies to enhance clinical research capacity in Zambia (2014) (0)
INVESTIGATING IMMUNE SIGNATURES IN MALARIA-EXPOSED CHILDREN (2018) (0)
Adaptation of Plasmodium falciparum to its transmission environment (2017) (0)
Morbidity and co-morbidity in children with signs of severe malaria [MIM-JB-166260] (2005) (0)
Malaria Vaccine Development: Progress to Date (2015) (0)
Correction: Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4+ CD25high T Cells with Susceptibility in Kenyans (2011) (0)
Malaria (2021) (0)
Inhibitory Antibodies-Specific Growth Plasmodium falciparum High-Throughput Methods To Measure Development and Optimization of (2006) (0)
Common antimalarial drugs do not affect the metabolism of diazepam and desmethyldiazepam by human liver microsomes (1996) (0)
A novel mis‐sense mutation in the platelet glycoprotein CD36 is associated with protection from malaria (2000) (0)
PARASITIZED ERYTHROCYTE BINDING TO THROMBOSPONDIN IN FALCIPARUM-MALARIA (1986) (0)
falciparum Plasmodium Exposure Is Suppressed by Responses after Vaccination or Natural γ The Induction and Persistence of T Cell IFN-and (2007) (0)
Replication data for: Characterization of naturally acquired immunity to a panel of antigens expressed in mature P. falciparum gametocytes (2021) (0)
in Children with Mild Malaria Erythrocyte Membrane Protein 1 falciparum Plasmodium T Cell Responses to the + CD4 (2014) (0)
INDICATORS OF LIFE-THREATENING MALARIA - REPLY (1995) (0)
A detailed study of the kinetics of antibody responses to Plasmodium falciparum merozoite antigens [MIM-SK-10044] (2005) (0)
Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population (2016) (0)
Diagnosis of bacterial meningitis - Reply (2001) (0)
Neurological involvement in acute falciparum malaria in Kenyan children. Authors reply [letter] (2007) (0)
P.83 Glucose production and influence of alanine infusion in children with malaria (1995) (0)
A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children [version 1; peer review: 1 approved, 2 approved with reservations] (2020) (0)
Ochola-Oyier, Lynette Isabella (2014) Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESIS- (2019) (0)
The activities of various antimalarial drugs on Plasmodium falciparum isolates in Kilifi Kenya and studies on mechanisms of resistance (2011) (0)
with sickle cell anemia on the coast of Kenya malaria in children living Plasmodium falciparum High mortality from (2013) (0)
Neurological events and abnormalities in SCD cohort in Tanzania (2011) (0)
THE RELATIONSHIP BETWEEN MALARIA TRANSMISSION INTENSITY, CLINICAL DISEASE AND MORTALITY IN AN AREA OF DECLINING TRANSMISSION (2008) (0)
Characterisation of the naturally occurring antibody response to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) [MIM-cm-190904] (2005) (0)
Albumin reduces the risk of death in children with severe malaria and acidosis in a Phase II randomised controlled trial of volume expansion [MIM-KM-16564] (2005) (0)
The acquisition of invasion inhibitory antibodies and antibodies to erythrocyte invasion ligands of Plasmodium falciparum (2007) (0)
Phenobarbital for children with cerebral malaria (2000) (0)
Factors affecting B cell response to Plasinodium falciparum infection. (2008) (0)
Autoantibodies against ion channels in children who develop seizures following CNS infection (2016) (0)
The remaining unknowns: A determination of the current research priorities for COVID-19 by the global health research community (2020) (0)
Hepatitis B Virus Infection as a 1 Neglected Tropical Disease 2 3 (2017) (0)
Transcranial doppler in sickle cell disease in Africa (2007) (0)
A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies (2016) (0)
Use of gene expression studies to investigate the human immunological response to malaria infection (2019) (0)
Clonal Antigenic Variation in P. Falciparum (1993) (0)
Brain swelling andischaemia inKenyans with cerebral malaria (2011) (0)
Intermittentt sulphadoxine-pyrimethaminee to prevent severe anaemiaa secondary to malaria in pregnancy : : a randomised placebo-controlledd trial (2007) (0)
Single nucleotide polymorphisms in trap associate with severe malarial disease: A novel parasite virulence gene (2006) (0)
Identifying Prognostic Factors of Severe Metabolic Acidosis and Acute Kidney Injury in African Children with Severe Falciparum Malaria: A Secondary Analysis of A Randomised Trial (2021) (0)
Using the controlled human malaria infection model to study immunity to malaria (2015) (0)
Spectrum of cerebral blood flow velocities measured by transcranial Doppler ultrasonography in children with sickle cell disease in Africa (2005) (0)
The role of Pfrh invasion ligands as targets of antibodies that protect against Plasmodium falciparum malaria (2007) (0)
T Cell Exhaustion Is Associated with Phenotypic Evidence of B Plasmodium falciparum Chronic Exposure to Crompton (2013) (0)
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity (2017) (0)
Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast (2016) (0)
Clinical and laboratory features of homozygous sickle cell patients in Tanzania; Malaria, infections and cerebral blood flow velocity (2005) (0)
Correction: Interactions between Age and ITN Use Determine the Risk of Febrile Malaria in Children (2011) (0)
Anticonvulsants in severe childhood malaria (2002) (0)
The erythrocyte binding antigens and PfRh proteins are targets of Plasmodium falciparum invasioninhibitory antibodies. (2008) (0)
Edinburgh Explorer Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2018) (0)
Paediatric anaemia at community and hospital levels in high and low intensity P. falciparum transmission areas of Kenya. (1997) (0)
A comparison of rectal Diazepam and Paraldehyde in the treatment of acute convulsions in a District Hospital (2001) (0)
An analysis of ICAM-1 in Plasmodium falciparum malaria. (2008) (0)
parasitized by Plasmodium falciparum Rheological analysis of the adhesive interactions of red blood cells (2011) (0)
TRANSPORTER GENES OTHER THAN PMDR1 AND PFCRT MAY ALTER THE RESPONSE OF PLASMODIUM FALCIPARUM TO LUMEFANTRINE (2010) (0)
CLINICAL AND ANGIOGRAPHIC FEATURES OF RETINAL LESIONS IN CHILDREN WITH SEVERE MALARIA (1995) (0)
INTERACTIONS OF MALARIA-INFECTED ERYTHROCYTES WITH ICAM-1 AND VASCULAR ENDOTHELIUM (1993) (0)
Distinct var gene subsets associated with low host age and disease severity in Kenya. (2008) (0)
Variants Kenya: Evidence for Rare and Prevalent falciparum Erythrocyte Surface Antigens in Antibody Recognition of Plasmodium (2013) (0)
The acquisition of invasion inhibitory antibodies and antibodies to erythrocyte invasion ligands of P-falciparum. (2008) (0)
Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure (2011) (0)
Acquired Immunity Antibodies and Function To Evade Naturally Are Targets of Human Inhibitory falciparum Plasmodium Erythrocyte-Binding Antigens of Cowman (2013) (0)
Preventive Sulfadoxine-Pyrimethamine Treatment of Primigravidae Reduces Levels of Plasma Immunoglobulin G, Which Protects against Pregnancy-Associated Plasmodium falciparum Malaria (2004) (0)
Halofantrine pharmacokinetics in Kenyan children with complicated and uncomplicated falciparum malaria (1995) (0)
Malaria vaccines. (1988) (0)
TUBERCULIN TESTING OF SCHOOL-CHILDREN (1956) (0)
Patarroyo's vaccine. (1993) (0)
Phenotypic variation in P-falciparum invasion of erythrocytes is a mechanism of immune evasion (2006) (0)
Tuberculosis and Mass Radiography (1956) (0)
Additional file 12: of Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2015) (0)
B.C.G. AND KELOIDS (1966) (0)
ERADICATION OF TUBERCULOSIS (1956) (0)
FEASIBILITY OF OPTIC-NERVE LASER-DOPPLER BLOOD-FLOW (F(ONH)) MEASUREMENTS IN CHILDREN WITH CEREBRAL MALARIA (1995) (0)
Rehabilitation of the Tuberculous: some Observations. (1955) (0)
THE IMPACT OF ACCESS TO PRIMARY HEALTH CARE ON THE INCIDENCE OF CLINICAL MALARIA IN CHILDREN (2008) (0)

This paper list is powered by the following services:

Other Resources About Kevin Marsh

en.wikipedia.org

What Schools Are Affiliated With Kevin Marsh ?

Kevin Marsh is affiliated with the following schools: